Zortress for Organ Transplant, Rejection Prophylaxis User Reviews
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Zortress (everolimus)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
"This is an exceptionally good drug for liver transplants. In fact, it is a monotherapy for me. One of the big selling points is that it does not create problems with kidneys, heart, lungs, etc.. as other drugs can and do down the road. I started with 6 mg/day --- went through an acute rejection at 6-weeks post-transplant (jumped up to 8 mg/day ad steroids) and weaned back down to a monotherapy and 6 mg in the first two years. After it was discovered that this drug had no impact on my neuroendocrine tumor progression, I quit the study and found a physician who would work with me to lower this drug. I am currently on 2 mg (subclinical dose) and doing fine, 8-years post-transplant. I recommend this drug and say just be patient if you are a new transplant person. After about 1.5 years, push to get off all other drugs except this one, you will have fewer problems in the long run."